WallStreetZenWallStreetZen

NASDAQ: SMLR
Semler Scientific Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Semler Scientific earnings were $37.0M for the trailing 12 months ending Jun 30, 2025, with 61.6% growth year over year. The latest SMLR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $66.9M, down 203.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SMLR reported annual earnings of $40.9M, with 98.7% growth. The next SMLR earnings date is Nov 3, 2025.

SMLR past earnings growth

How has SMLR's earnings growth performed historically?

Company
61.64%
Industry
84.35%
Market
34.06%
SMLR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SMLR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SMLR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SMLR earnings history

Current Revenue
$43.0M
Current Earnings
$37.0M
Current Profit Margin
86.2%

SMLR Return on Equity

Current Company
17.2%
Current Industry
15.2%
Current Market
30.7%
SMLR's Return on Equity (17.2%)... subscribe to Premium to read more.
High Return on Equity Performance

SMLR undefined

Current Company
12.9%
Current Industry
8.9%
SMLR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SMLR announces earnings.

SMLR undefined

Current Company
9.62%
Current Industry
10.6%
SMLR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SMLR vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SMLR$47.20M$37.05M+11.26%$3.75
BFLY-$51.92M-$62.83MN/A-$0.28
CARLN/AN/AN/AN/A
DCTH$1.54M$2.23MN/A$0.08
CBLL-$46.14M-$49.41MN/A-$0.96
View Top Medical Device Stocks

SMLR earnings dates

Next earnings date
Nov 3, 2025

Semler Scientific Earnings Reports & History FAQ

What were Semler Scientific's earnings last quarter?

On SMLR's earnings call on Invalid Date, Semler Scientific (NASDAQ: SMLR) reported Q2 2025 earnings per share (EPS) of $5.71, up Infinity% year over year. Total SMLR earnings for the quarter were $66.93 million. In the same quarter last year, Semler Scientific's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Semler Scientific stock.

When does Semler Scientific report earnings?

The next SMLR earnings call is Invalid Date. Add SMLR to your watchlist to be reminded of Semler Scientific's next earnings date.

Is Semler Scientific profitable or losing money?

As of the last Semler Scientific earnings report, Semler Scientific is currently profitable. Semler Scientific's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $37.05 million, a 134.19% increase year over year.

What was SMLR's earnings growth in the past year?

As of Semler Scientific's earnings date in Invalid Date, Semler Scientific's earnings has grown 61.64% year over year. This is 22.71 percentage points lower than the US Medical Devices industry earnings growth rate of 84.35%. SMLR earnings in the past year totalled $37.05 million.

What are Semler Scientific's earnings expectations?

The current EPS estimate for Semler Scientific's earnings report in Invalid Date is -$0.10.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.